WADA Publishes 2016 Prohibited List

(Ottawa, Ontario – October 22, 2015) – The Canadian Centre for Ethics in Sport (CCES) would like to alert the Canadian sport community that the World Anti-Doping Agency (WADA) has published the 2016 Prohibited List. The List will come into effect on January 1, 2016.

The 2016 Prohibited List, the Summary of Modifications, and the Monitoring Program are now available for download on WADA’s website in English and French.

There are very few changes to the 2016 List: the only additions are in the category S4, Hormone and Metabolic Modulators. “Insulin-mimetics were added to include all insulin-receptor agonists, and meldonium (mildronate) was added because of evidence of its use by athletes with the intention of enhancing performance.”

The List is an international standard identifying substances and methods prohibited in sport. It was first published in 1963 by the International Olympic Committee. Since 2004, WADA has been responsible for the preparation and publication of the List, which it updates every year.

Athletes can find out if their medications are prohibited using the following CCES resources, all of which will be updated on January 1, 2016, to reflect the new List. 

Athletes can apply for a medical exemption if they are prescribed a prohibited medication for the treatment of an illness or condition. The CCES Medical Exemption Wizard (www.cces.ca/medical-exemptions) can help athletes find out if they need to apply for an exemption, what to include in the application, and where to submit it.

Further reading:

The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.


For further information, please contact:
Megan Cumming
Manager, Corporate Communications
+1 613-521-3340 x3233